Saint Louis, Missouri, USA
Joined January 2015
- Tweets36
- Following49
- Followers63
- Likes263
FDA Approval of 18F-Flurpiridaz Is for PET: Stepping into a New Area of Myocardial Perfusion Imaging? pubmed.ncbi.nlm.nih.gov/4024…
1
40
Thanks very much!!! Very honored to have given this talk at Grand Rounds at Johns Hopkins Medicine, and seeing many friends again! 🙂
2
18
Thomas H Schindler retweeted
Terrific @hopkinsheart Grand Rounds today by Dr. Thomas Schindler @h_hellmut on PET/CT assessment of coronary morphology and flow. @CiccaroneCenter
Needs to be faster if you want to lose some calories Stephan ! :)
On my way to on-call STEMI. Lucky to be living in a small town (w/ large hospital) where I can bike to the cath lab on a summer night (or winter, when the time comes) and still arrive before the patient
#cardiotwitter @escardio @HolgerNef @JEscaned @ESC_President @Drroxmehran
102
Thomas H Schindler retweeted
On my way to on-call STEMI. Lucky to be living in a small town (w/ large hospital) where I can bike to the cath lab on a summer night (or winter, when the time comes) and still arrive before the patient
#cardiotwitter @escardio @HolgerNef @JEscaned @ESC_President @Drroxmehran
Angiography-Derived FFR as Novel Parameter in Assessing Flow-Limiting CAD? Commentary pubmed.ncbi.nlm.nih.gov/3711…
on Westra et al.
doi.org/10.1016/j.jcmg.2023.…
Comparable diagnostic accuracy of QFR and invasively measured FFR but low concordance with PET determined MFR.
1
62
Published in IJC Heart & Vasculature.
DOI: lnkd.in/gkCvdHnV
In this analysis in a symptomatic cardio-metabolic risk population, 54% had evidence of coronary microvascular dysfunction (CMD) as determined with PET. Thereof, 65% had classical CMD and 35% had endogen CMD.
2
55
Normally, editors take out insulting comments but sometimes they may miss it. I always tell my fellows, "when you want to publish, you need thick skin and don't take reviewer comments personally". Just keep going .....
2
Thomas H Schindler retweeted
Hellow Tweetverse! Good morning to all! @ucsf_echo @UCSF @UCSFMedicine @UCSFCardiology @ASE360 @hcmsociety @ethanweiss @RWASECEO @SLittleMD @ray_stainback @mswami001 @ErinMichos @iamritu @MasriAhmadMD @scauduro
Thomas H Schindler retweeted
This #WomensHistoryMonth, we're shining a spotlight on #RadWomen leaders at MIR.
Farrokh Dehdashti, MD, is the Drs. Barry A. & Marilyn J. Siegel Professor of Radiology, senior vice chair and division director of nuclear medicine.
18F-FDG Positron Emission Tomography in Myocardial Viability Assessment: A Practical and Time Efficient Protocol jnm.snmjournals.org/content/…
ALT Using a practical and time efficient protocol for i.v. glucose loading and insulin administration prior to 18F-FDG injection reduces the metabolic preparation period (MPP) by 61% as compared to oral glucose challenge that affords good-to-excellent image quality in 95% of ischemic cardiomyopathy patients. Overall, the 18F-FDG PET study for viability assessment in ischemic CMP can be performed in about 120 to 140 min. This practical and time efficient protocol should revamp the use of 18F-FDG PET in cardiac viability assessment in clinical practice
2
I believe this will be an ongoing investigation for years to come.... In the end there is much clinical reasoning when you weigh in all factors such as age, symptoms, comorbities, LVEF etc. for optimal patient care!
Thomas H Schindler retweeted
Ha, we will see!
A long-awaited US chest pain guidelines update is now expected for Aug/Sept, but whether the new advice will match the approach taken in Europe/UK remains unclear tctmd.com/news/new-guideline… @ToddVillinesMD @JWeirMcCall @Steph_Achenbach @RonBlankstein @CardiacCTGuy #SCCT2021
